# clm_B43E99166EDA

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 10,832,000,000 United States dollar  
valid_from: 2019-03-31  
valid_to: 2019-06-30  
published: 2019-05-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_15DDEC9FE673  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 10,832,000,000 United States dollar", as of 2019-03-31 (until 2019-06-30). Claim clm_B43E99166EDA, https://asof.is/claim/clm_B43E99166EDA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815419000018/0000318154-19-000018-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815419000018/0000318154-19-000018-index.htm (primary, SEC EDGAR 10-Q Q1 FY2019, published 2019-05-01)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 12,500,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_B43E99166EDA](/claim/clm_B43E99166EDA.md) | [clm_84D402BD4390](/claim/clm_84D402BD4390.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.